The effects of bis(7) tacrine, a novel dimeric acetylcholinesterase (AChE) inhibitor, on glutamate induced cell injury were investigated in primary cerebral cortical neurons of rats. Exposure of cultured neurons (1...The effects of bis(7) tacrine, a novel dimeric acetylcholinesterase (AChE) inhibitor, on glutamate induced cell injury were investigated in primary cerebral cortical neurons of rats. Exposure of cultured neurons (12 days after plating) to 0.5 mmol/L glutamate for 30 min resulted in significant cell damage. Pretreatment with bis(7) tacrine (0.03 1.0 μmol/L) reduced the glutamate induced neurotoxicity in a concentration dependent manner and the maximal response was seen at 1 μmol/L with approximately 30% protection. A receptor binding assay showed that bis(7) tacrine can completely displace MK 801 binding to rat cortical membrane with an IC 50 of 0.57 μmol/L. These findings suggest that bis(7) tacrine can directly interact with N methyl D aspartate receptor channel complex, which may contribute to the inhibitor's protective effects against glutamate induced excitotoxicity. Thus, it is possible that anti glutamate/anti AChE synergism is responsible for potentially better Alzheimer's therapy of bis(7) tacrine relative to tacrine.展开更多
Neurodegenerative diseases such as Alzheimer's, Huntington's and Parkinson's diseases have multifaceted nature because of the different factors contributing to their progression. The complex nature of neur...Neurodegenerative diseases such as Alzheimer's, Huntington's and Parkinson's diseases have multifaceted nature because of the different factors contributing to their progression. The complex nature of neurodegenerative diseases has developed a pressing need to design multitarget-directed ligands to address the complementary pathways involved in these diseases. The major enzyme targets for development of therapeutics for Alzheimer's disease are cholinesterase and β-secretase enzymes. In this review, we discuss recent advances in profiling single target inhibitors based on these enzymes to multitarget-directed ligands as potential therapeutics for this devastating disease. In addition, therapeutics based on iron chelation strategy are discussed as well.展开更多
2H-3,l-Pyrazolo[3,4-e]oxazines (5a-c) and tacrine analogies (6a-c) were designed and prepared using 5-amino-4-cyanopyrazole (7) and cycloketones (2a-c) as reactants. The study demonstrated that the new conversion exis...2H-3,l-Pyrazolo[3,4-e]oxazines (5a-c) and tacrine analogies (6a-c) were designed and prepared using 5-amino-4-cyanopyrazole (7) and cycloketones (2a-c) as reactants. The study demonstrated that the new conversion existed in the Friedlander reaction of o-aminocyanopyrazole with cycloketones. (C) 2007 Jia Rong Li. Published by Elsevier B.V. on behalf of Chinese Chemical Society. All rights reserved.展开更多
8,9,12-Trihydro-9,9-pentamethylene- 12-（3-nitrophenyl）- 11H-naphtho[ 1＇,25,6]- pyrano[2,3-d]pyfimidin- 11 （10H）-one 1, another conversion product of Ffiedlandler reaction, has been synthesized by the reaction of ...8,9,12-Trihydro-9,9-pentamethylene- 12-（3-nitrophenyl）- 11H-naphtho[ 1＇,25,6]- pyrano[2,3-d]pyfimidin- 11 （10H）-one 1, another conversion product of Ffiedlandler reaction, has been synthesized by the reaction of 2-amino-4-（3-nitrophenyl）-4H-benzo[f]chromene-3-carbonitrile 2 with cyclohexanone in the presence of Lewis acid catalysts. The crystal of the title compound 1 THF solvate, C60H62N6O10, was obtained and determined by X-ray diffraction method. The crystal is of triclinic, space group P1 with a = 11.4633（11）, b = 12.6247（12）, c = 19.658（2）A, α = 72.642（8）, β = 89.045（9）, γ = 68.340（5）°, V = 2509.6（4）, Z = 2, De = 1.359 g/cm^3, F（000） = 1088, Mr = 1027.16, the final R = 0.0674 and wR = 0.1869 with Ⅰ 〉 2σ（Ⅰ） and the goodness-of-fit S = 1.045 on F^2. The pyrimidine ring has an envelope conformation, linked with a six-membered ring through a spiro C atom. The crystal packing of 1 THF solvate is stabilized by N-H…O hydrogen bonds, and π-π stacking interaction occurs between two adjacent nearly planar molecules of 1.展开更多
文摘The effects of bis(7) tacrine, a novel dimeric acetylcholinesterase (AChE) inhibitor, on glutamate induced cell injury were investigated in primary cerebral cortical neurons of rats. Exposure of cultured neurons (12 days after plating) to 0.5 mmol/L glutamate for 30 min resulted in significant cell damage. Pretreatment with bis(7) tacrine (0.03 1.0 μmol/L) reduced the glutamate induced neurotoxicity in a concentration dependent manner and the maximal response was seen at 1 μmol/L with approximately 30% protection. A receptor binding assay showed that bis(7) tacrine can completely displace MK 801 binding to rat cortical membrane with an IC 50 of 0.57 μmol/L. These findings suggest that bis(7) tacrine can directly interact with N methyl D aspartate receptor channel complex, which may contribute to the inhibitor's protective effects against glutamate induced excitotoxicity. Thus, it is possible that anti glutamate/anti AChE synergism is responsible for potentially better Alzheimer's therapy of bis(7) tacrine relative to tacrine.
文摘Neurodegenerative diseases such as Alzheimer's, Huntington's and Parkinson's diseases have multifaceted nature because of the different factors contributing to their progression. The complex nature of neurodegenerative diseases has developed a pressing need to design multitarget-directed ligands to address the complementary pathways involved in these diseases. The major enzyme targets for development of therapeutics for Alzheimer's disease are cholinesterase and β-secretase enzymes. In this review, we discuss recent advances in profiling single target inhibitors based on these enzymes to multitarget-directed ligands as potential therapeutics for this devastating disease. In addition, therapeutics based on iron chelation strategy are discussed as well.
文摘2H-3,l-Pyrazolo[3,4-e]oxazines (5a-c) and tacrine analogies (6a-c) were designed and prepared using 5-amino-4-cyanopyrazole (7) and cycloketones (2a-c) as reactants. The study demonstrated that the new conversion existed in the Friedlander reaction of o-aminocyanopyrazole with cycloketones. (C) 2007 Jia Rong Li. Published by Elsevier B.V. on behalf of Chinese Chemical Society. All rights reserved.
基金supported by the Beijing Institute of Technology (No.20060542021)
文摘8,9,12-Trihydro-9,9-pentamethylene- 12-（3-nitrophenyl）- 11H-naphtho[ 1＇,25,6]- pyrano[2,3-d]pyfimidin- 11 （10H）-one 1, another conversion product of Ffiedlandler reaction, has been synthesized by the reaction of 2-amino-4-（3-nitrophenyl）-4H-benzo[f]chromene-3-carbonitrile 2 with cyclohexanone in the presence of Lewis acid catalysts. The crystal of the title compound 1 THF solvate, C60H62N6O10, was obtained and determined by X-ray diffraction method. The crystal is of triclinic, space group P1 with a = 11.4633（11）, b = 12.6247（12）, c = 19.658（2）A, α = 72.642（8）, β = 89.045（9）, γ = 68.340（5）°, V = 2509.6（4）, Z = 2, De = 1.359 g/cm^3, F（000） = 1088, Mr = 1027.16, the final R = 0.0674 and wR = 0.1869 with Ⅰ 〉 2σ（Ⅰ） and the goodness-of-fit S = 1.045 on F^2. The pyrimidine ring has an envelope conformation, linked with a six-membered ring through a spiro C atom. The crystal packing of 1 THF solvate is stabilized by N-H…O hydrogen bonds, and π-π stacking interaction occurs between two adjacent nearly planar molecules of 1.
